Rockefeller Capital Management L.P. lessened its holdings in Centene Co. (NYSE:CNC - Free Report) by 3.1% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,565,215 shares of the company's stock after selling 49,543 shares during the period. Rockefeller Capital Management L.P. owned 0.31% of Centene worth $117,830,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. WR Wealth Planners LLC raised its position in shares of Centene by 41.4% during the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company's stock valued at $31,000 after buying an additional 137 shares in the last quarter. Whittier Trust Co. lifted its stake in Centene by 10.0% during the second quarter. Whittier Trust Co. now owns 1,562 shares of the company's stock worth $104,000 after purchasing an additional 142 shares during the last quarter. Mount Yale Investment Advisors LLC boosted its holdings in shares of Centene by 2.1% in the 3rd quarter. Mount Yale Investment Advisors LLC now owns 8,082 shares of the company's stock worth $608,000 after purchasing an additional 167 shares in the last quarter. Meridian Management Co. increased its position in shares of Centene by 0.3% during the 2nd quarter. Meridian Management Co. now owns 64,721 shares of the company's stock valued at $4,291,000 after purchasing an additional 189 shares during the last quarter. Finally, E Fund Management Co. Ltd. lifted its position in Centene by 6.4% in the 2nd quarter. E Fund Management Co. Ltd. now owns 3,309 shares of the company's stock worth $219,000 after buying an additional 199 shares during the last quarter. 93.63% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In other Centene news, CFO Andrew Lynn Asher bought 17,200 shares of the stock in a transaction dated Wednesday, November 13th. The stock was purchased at an average cost of $58.14 per share, for a total transaction of $1,000,008.00. Following the completion of the acquisition, the chief financial officer now owns 486,847 shares of the company's stock, valued at approximately $28,305,284.58. This trade represents a 3.66 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Sarah London bought 4,117 shares of the business's stock in a transaction dated Friday, November 8th. The stock was bought at an average cost of $60.80 per share, for a total transaction of $250,313.60. Following the completion of the purchase, the chief executive officer now owns 667,229 shares of the company's stock, valued at approximately $40,567,523.20. The trade was a 0.62 % increase in their position. The disclosure for this purchase can be found here. Insiders own 0.33% of the company's stock.
Wall Street Analysts Forecast Growth
Several research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Centene from $82.00 to $87.00 and gave the stock a "hold" rating in a research note on Friday, August 2nd. StockNews.com downgraded shares of Centene from a "strong-buy" rating to a "buy" rating in a research note on Monday, October 28th. Stephens reiterated an "equal weight" rating and issued a $78.00 price objective on shares of Centene in a report on Monday, August 5th. Robert W. Baird dropped their target price on Centene from $83.00 to $66.00 and set a "neutral" rating for the company in a report on Friday, October 25th. Finally, Barclays lowered their price objective on Centene from $97.00 to $91.00 and set an "overweight" rating for the company in a research report on Tuesday, October 29th. Seven research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $83.92.
Read Our Latest Analysis on Centene
Centene Trading Up 0.1 %
NYSE:CNC traded up $0.07 during trading hours on Friday, hitting $60.00. The company had a trading volume of 2,380,121 shares, compared to its average volume of 4,044,422. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10. Centene Co. has a 52 week low of $57.20 and a 52 week high of $81.42. The company has a market capitalization of $30.29 billion, a PE ratio of 10.40, a price-to-earnings-growth ratio of 0.82 and a beta of 0.49. The stock has a 50-day moving average price of $65.43 and a 200 day moving average price of $70.04.
About Centene
(
Free Report)
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Read More
Before you consider Centene, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.
While Centene currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.